Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Spliceosomal Disruption of the Non-Canonical SWI/SNF Chromatin Remodeling Complex in SF3B1 Mutant Leukemias

Daichi Inoue, MD PhD, Chew Guo-Liang, Bo Liu, PhD, Stanley C Lee, PhD, Brittany C Michel, Joey Pangallo, B.S., Andrew R D'Avino, Khrystyna North, Lillian E Bitner, BSc, Muran Xiao, Susumu Kobayashi, Akihide Yoshimi, MD PhD, Hana Cho, MSc, Sydney X Lu, MD PhD, Justin Taylor, MD, Cigall Kadoch, PhD, Robert K. Bradley, PhD, Omar Abdel-Wahab, MD

Blood (2019) 134 (Supplement_1): 637.

https://doi.org/10.1182/blood-2019-124616

Published: 2019

Journal Articles

Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include up-Regulated Innate Immune Modulators

Ahmad Faisal Karim, PhD, Anthony R. Soltis, PhD, Nadia P Ewing, MD, Clifton L. Dalgard, PhD, Matthew D. Wilkerson, PhD, Kathleen P. Pratt, PhD

Blood (2019) 134 (Supplement_1): 160.

https://doi.org/10.1182/blood-2019-124855

Published: 2019

Journal Articles

Gp1ba-Cre or Pf4-Cre : pick your poison

Kandace Gollomp, Mortimer Poncz

Blood (2019) 133 (4): 287–288.

https://doi.org/10.1182/blood-2018-11-887513

Published: 2019

Journal Articles

Impact of Bioflavonoid Exposure on DNA Damage Response and of Non-Homologous End Joining (NHEJ) Pathway Repair Proteins in Stem Cells

Anindita Ghosh, MBBS, MSc, Christine Richardson, PhD

Blood (2017) 130 (Supplement 1): 3796.

https://doi.org/10.1182/blood.V130.Suppl_1.3796.3796

Published: 2017

Journal Articles

Functional Consequences of Spliceosome Mutations

Stephanie Halene, MD PhD

Blood (2016) 128 (22): SCI-18.

https://doi.org/10.1182/blood.V128.22.SCI-18.SCI-18

Published: 2016

Journal Articles

Blood ’s 70th anniversary: arsenic—from poison pill to magic bullet

James D. Griffin

Blood (2016) 127 (14): 1729–1730.

https://doi.org/10.1182/blood-2015-10-638650

Published: 2016

Journal Articles

Transfusion with Washed vs. Unwashed Packed Red Cells in Coronary Artery Bypass Graft (CABG) Surgery: Major Outcome Differences

Wenche Jy, PhD, Orlando Gomez-Marin, PhD, Tomas A Salerno, MD, Anthony Panos, MD, Donald Williams, MD, Sherry Shariatmadar, MD, Max E Johansen, BS, Carlos Bidot, BS, Lawrence L Horstman, BS, Yeon-Soong Ahn, MD

Blood (2014) 124 (21): 2887.

https://doi.org/10.1182/blood.V124.21.2887.2887

Published: 2014

Journal Articles

Downregulation of BRCA1 Protein in BCR-ABL1–positive Cells Depends on Tiar-Mediated Repression of BRCA1 mRNA Translation

Paulina Podszywalow-Bartnicka, PhD, Magdalena Wolczyk, MSc, Monika Kusio-Kobialka, PhD, Kamila Wolanin, PhD, Krzysztof Skowronek, PhD, Margaret Nieborowska-Skorska, MD PhD, Yashodhara Dasgupta, PhD, Tomasz Skorski, MD PhD, Katarzyna Piwocka, PhD

Blood (2014) 124 (21): 3129.

https://doi.org/10.1182/blood.V124.21.3129.3129

Published: 2014

Journal Articles

The Poison Oligonucleotide F10 Is Efficiently Taken Up By, and Highly Effective Against, Acute Lymphoblastic Leukemia While Sparing Normal Hematopoietic Cells

Timothy Pardee, MD, PhD, Jamie Jennings-Gee, PhD, Kristin Stadelman, MS, David L. Caudell, DVM, PhD, William Gmeiner, PhD

Blood (2013) 122 (21): 2674.

https://doi.org/10.1182/blood.V122.21.2674.2674

Published: 2013

Journal Articles

Targeting The Nuclear Export Signal In Multiple Myeloma

Joel G Turner, PhD, Thomas C Rowe, PhD, David Ostrov, PhD, Jana L Dawson, BS, Danielle Pernazza, PhD, Nicholas J Lawrence, Ph.D., Daniel M Sullivan, MD

Blood (2013) 122 (21): 1925.

https://doi.org/10.1182/blood.V122.21.1925.1925

Published: 2013

Journal Articles

System for Rapid and Reproducible Identification of MLL-AF9 Translocations Induced by Dietary Compounds and Nutritional Supplements

Carol Greer Vestal, Bhawana Bariar, Christine Richardson, PhD

Blood (2012) 120 (21): 1275.

https://doi.org/10.1182/blood.V120.21.1275.1275

Published: 2012

Journal Articles

A Rationale to Enhance the Response to Antimitotic Therapy in Acute Myeloid Leukemia

Dominik Schnerch, MD, Julia Felthaus, Monika Engelhardt, Ralph Wäsch, MD

Blood (2012) 120 (21): 1332.

https://doi.org/10.1182/blood.V120.21.1332.1332

Published: 2012

Journal Articles

Drug-Induced Cytokine Release Sensitizes Protective Tumor Microenvironments to Antibody- Mediated Therapy

Christian P. Pallasch, MD, Leskov Ilya, MD, PhD, Yadira M Soto, Christian J. Braun, MD, Nadine Kutsch, MD, Adam Drake, PhD, Lukas P. Frenzel, MD, Bettina Iliopoulou, PhD, Nico van Rooijen, PhD, Clemens Wendtner, MD, Michael Hallek, MD, Jianzhu Chen, PhD, Michael T Hemann, PhD

Blood (2012) 120 (21): 1335.

https://doi.org/10.1182/blood.V120.21.1335.1335

Published: 2012

Journal Articles

Casein Kinase II Modulates Topoisomerase II Alpha Nuclear Export and Drug Sensitivity in Multiple Myeloma

Joel G Turner, PhD, Jana L Dawson, BS, Daniel M Sullivan, MD

Blood (2012) 120 (21): 4032.

https://doi.org/10.1182/blood.V120.21.4032.4032

Published: 2012

Journal Articles

Mechanisms in Leukemia-Associated Chromosomal Translocations: Novel, High-Throughput Sequencing Method to Detect Topoisomerase II (TOP2) Cleavage Complexes Genome-Wide with Exact Base Resolution,

Carolyn A. Felix, MD, Marie L. Carillo, MS, Karen A. Urtishak, PhD, Isabelle C. Dragomir, BS, Michele E. Paessler, DO, Andrew D. Bantly, BS, Marybeth Helfrich, BS, Li-San Wang, PhD, Brian D. Gregory, PhD

Blood (2011) 118 (21): 3445.

https://doi.org/10.1182/blood.V118.21.3445.3445

Published: 2011

Journal Articles

The Potent STAT3/5 Inhibitor, BP-1-102 Demonstrates Significant Anti-Tumor Activity Against Waldenström Macroglobulinemia

Danielle C Croucher, Victor H Jimenez-Zepeda, MD, PD, Zhi Hua Li, Ellen Wei, Brent DG Page, James Turkson, Patrick T Gunning, Suzanne Trudel, MD, MSC, FRCPC

Blood (2011) 118 (21): 5101.

https://doi.org/10.1182/blood.V118.21.5101.5101

Published: 2011

Journal Articles

The Spindle Checkpoint Protein BubR1 Is Differentially Expressed in the Lymphatic and Myeloid Lineage and Is a Determinator of Response to Spindle Poisons

Dominik Schnerch, MD, Marie Follo, PhD, Andrea Schmidts, Julika Krohs, Julia Felthaus, Monika Engelhardt, MD, Ralph Wäsch

Blood (2011) 118 (21): 1407.

https://doi.org/10.1182/blood.V118.21.1407.1407

Published: 2011

Journal Articles

USP44 Is Highly Over-Expresed In T-Cell Acute Lymphoblastic Leukemia and Leads to the Development of Chromosome Missegregation and Aneupoloidy

Paul J. Galardy, MD, Ying Zhang, PhD

Blood (2010) 116 (21): 29.

https://doi.org/10.1182/blood.V116.21.29.29

Published: 2010

Journal Articles

Novel Drug Targets to Overcome De Novo Drug-Resistance In Multiple Myeloma

Joel G Turner, PhD, Thomas C Rowe, PhD, David Ostrov, Jana L Dawson, BS, Elizabeth Ciaravino, BS, Daniel Sullivan, MD

Blood (2010) 116 (21): 3006.

https://doi.org/10.1182/blood.V116.21.3006.3006

Published: 2010

Journal Articles

Mobilizing Chemotherapy Followed by G-CSF, Additioned by Plerixafor on Demand, Is Safe and Allows Both Adequate PBSC (Peripheral Blood Stem Cell) Collection and Safe ASCT (Autologous Stem Cell Transplantation) In Multiple Myeloma and Lymphoma Patients

Immacolata Attolico, Vincenzo Pavone, MD, MD, CH, Angelo Ostuni, Maurizio Musso, Alessandra Crescimanno, Massimo Martino, MD, Pasquale Iacopino, Giuseppe Milone, MD, Patrizia Tedeschi, Attilio Olivieri

Blood (2010) 116 (21): 2257.

https://doi.org/10.1182/blood.V116.21.2257.2257

Published: 2010

NARROW

Spliceosomal Disruption of the Non-Canonical SWI/SNF Chromatin Remodeling Complex in SF3B1 Mutant Leukemias

Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include up-Regulated Innate Immune Modulators

Gp1ba-Cre or Pf4-Cre : pick your poison

Impact of Bioflavonoid Exposure on DNA Damage Response and of Non-Homologous End Joining (NHEJ) Pathway Repair Proteins in Stem Cells

Functional Consequences of Spliceosome Mutations

Blood ’s 70th anniversary: arsenic—from poison pill to magic bullet

Transfusion with Washed vs. Unwashed Packed Red Cells in Coronary Artery Bypass Graft (CABG) Surgery: Major Outcome Differences

Downregulation of BRCA1 Protein in BCR-ABL1–positive Cells Depends on Tiar-Mediated Repression of BRCA1 mRNA Translation

The Poison Oligonucleotide F10 Is Efficiently Taken Up By, and Highly Effective Against, Acute Lymphoblastic Leukemia While Sparing Normal Hematopoietic Cells

Targeting The Nuclear Export Signal In Multiple Myeloma

System for Rapid and Reproducible Identification of MLL-AF9 Translocations Induced by Dietary Compounds and Nutritional Supplements

A Rationale to Enhance the Response to Antimitotic Therapy in Acute Myeloid Leukemia

Drug-Induced Cytokine Release Sensitizes Protective Tumor Microenvironments to Antibody- Mediated Therapy

Casein Kinase II Modulates Topoisomerase II Alpha Nuclear Export and Drug Sensitivity in Multiple Myeloma

Mechanisms in Leukemia-Associated Chromosomal Translocations: Novel, High-Throughput Sequencing Method to Detect Topoisomerase II (TOP2) Cleavage Complexes Genome-Wide with Exact Base Resolution,

The Potent STAT3/5 Inhibitor, BP-1-102 Demonstrates Significant Anti-Tumor Activity Against Waldenström Macroglobulinemia

The Spindle Checkpoint Protein BubR1 Is Differentially Expressed in the Lymphatic and Myeloid Lineage and Is a Determinator of Response to Spindle Poisons

USP44 Is Highly Over-Expresed In T-Cell Acute Lymphoblastic Leukemia and Leads to the Development of Chromosome Missegregation and Aneupoloidy

Novel Drug Targets to Overcome De Novo Drug-Resistance In Multiple Myeloma

Mobilizing Chemotherapy Followed by G-CSF, Additioned by Plerixafor on Demand, Is Safe and Allows Both Adequate PBSC (Peripheral Blood Stem Cell) Collection and Safe ASCT (Autologous Stem Cell Transplantation) In Multiple Myeloma and Lymphoma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only